Tue, Jul 22, 2014, 11:31 AM EDT - U.S. Markets close in 4 hrs 29 mins

Recent

% | $
Click the to save as a favorite.

Amarin Corporation plc Message Board

  • xdexletx xdexletx Feb 6, 2013 2:51 PM Flag

    Other connections that might prove useful. Elan's Chairman and board member.

    Robert Graham, who is now Chairman of Elan, and former high exec. at GSK, has another person at Elan, that has an interesting background. He is Andrew von Eschenbach, now an Elan director. If he sounds familiar, he should. He was Head of the FDA from 2005-09. Some of you may remember his involvement in the delay of DNDN's Provenge treatment for Prostate Cancer, that was hijacked when it was first delayed a few years and then only allowed later-stage use, when it was approved.

    Irregardless, he has connections in the industry and the FDA which might prove useful, particularly if a company he was looking to buy was looking for an approval, like NCE for Vascepa, as an example. He probably knows a few at the patent office, as well. I have to think there is a lot of talk between them and JZ about the price.

    Sentiment: Strong Buy

 
AMRN
1.60+0.08(+5.26%)11:29 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.